Rezultati pretraživanja
  1. 30. sij

    BioCardia Rating Lowered to Sell at Zacks Investment Research

  2. 27. sij

    NEW Biotech report will be available here 9:15AM EST tomorrow 01/28/20 , , , , , , , , , , , , , , , , , , , ,

  3. 17. sij

    Jan 13-17 Alerts worth noting PT2: $1.39 —> $2.13 ••• 53% $6.86 —> $8.80 ••• 28% $1.35 —> $2.38 ••• 76% $4.04 —> $6.75 ••• 67% $3.60 —> $6.09 ••• 69%

  4. 15. sij

    : STILL FLYING UNDER MANY RADARS DISRUPTIVE TECH... ** PARTNERS ALL GET IT--SOON THE MASSES ALSO

  5. 14. sij
  6. 13. sij
    Prikaži ovu nit
  7. 13. sij

    Made $811.50 on 2 shorts. Mainly on $650. Thanks Tim

  8. 13. sij
  9. BioCardia Receives FDA 510k Approval For 8F Morph DNA Deflectable Guide Catheter

  10. 30. stu 2019.

    One I never heard of ??Ongoing BCDA-01 Phase 3 trial heart failure based on promising Phase 2 data ─ In a Phase 2 trial BCDA-01 met primary safety endpoint with no treatment emergent major adverse cardiac events (MACE) at 30 days.

  11. The calm before the upside storm in .

  12. 16. lis 2019.
  13. 10. lis 2019.

    +Initiations 10/10: -Initiations 10/10:

  14. 28. ruj 2019.

    Spent time going over some low float names, including specifically those with <3 million share float Own Others Buys Neutral Sell

    Prikaži ovu nit
  15. Last day to get 40% off our annual subscription! Use code “NEWSITE”!

  16. 18. ruj 2019.

    It's hump day and FOMC day so I'm in no hurry to trade but here's what I MAY be trading IF we get an A+ Setup:

  17. 18. ruj 2019.
  18. 17. ruj 2019.
    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.